L. G. Dressler - Concepedia

Author

L. G. Dressler

University of North Carolina at Chapel Hill

Also Known As

L DRESSLER, L Dressler, L G Dressler, L. Dressler, L. G. Dressler, L.G. Dressler, LG Dressler

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill Memorial Sloan Kettering Cancer Center Duke Medical Center The University of Texas Health Science Center at San Antonio Dana-Farber Cancer Institute

About

L. G. Dressler is an author at University of North Carolina at Chapel Hill specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	602
2	Health Sciences	6	6	383
3	Cell Biology	4	4	120
4	Public Health	2	2	40
5	Biostatistics	2	2	93

L. G. Dressler

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
DNA flow cytometry in solid tumors: practical aspects and clinical applications. L. G. Dressler, S A Bartow PubMed	1989	152
CALGB 9840: Phase III study of weekly (W) paclitaxel (P) via 1-hour(h) infusion versus standard (S) 3h infusion every third week in the treatment of metastatic breast cancer (MBC), with trastuzumab (T) for HER2 positive MBC and randomized for T in HER2 normal MBC Andrew D. Seidman, Donald A. Berry, C. Cirrincione, Journal of Clinical Oncology Breast OncologyCancer ManagementPathologyPharmacotherapyW P	2004	133
Emerging Impact of Flow Cytometry in Predicting Recurrence and Survival in Breast Cancer Patients W L McGuire, L. G. Dressler JNCI Journal of the National Cancer Institute Flow CytometryBreast OncologyBreast Cancer PatientsMedicinePathology	1985	125
Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. Gary M. Clark, M. Mathieu, Marilyn A. Owens, Journal of Clinical Oncology	1992	118
Hematogones: a multiparameter analysis of bone marrow precursor cells TA Longacre, Kathryn Foucar, S. S. Crago, Blood	1989	108
Evaluation of a modeling system for S-phase estimation in breast cancer by flow cytometry. L. G. Dressler, Larry C. Seamer, Marilyn A. Owens, PubMed Modeling SystemBreast OncologyPathologyImmunophenotypingTumor Biology	1987	71
Factor V Leiden Mutation and Thromboembolism Risk in Women Receiving Adjuvant Tamoxifen for Breast Cancer J. E. Garber, Susan Halabi, Sara M. Tolaney, JNCI Journal of the National Cancer Institute	2010	62
CALGB 9840: Phase III study of weekly (W) paclitaxel (P) via 1-hour(h) infusion versus standard (S) 3h infusion every third week in the treatment of metastatic breast cancer (MBC), with trastuzumab (T) for HER2 positive MBC and randomized for T in HER2 normal MBC Andrew D. Seidman, D. A. Berry, C. Cirrincione, Journal of Clinical Oncology Breast OncologyCancer ManagementPathologyPharmacotherapyW P	2004	60
Preferences for return of incidental findings from genome sequencing among women diagnosed with breast cancer at a young age Kimberly A. Kaphingst, Jennifer Ivanovich, Barbara B. Biesecker, Clinical Genetics	2015	53
Emerging Impact of Flow Cytometry in Predicting Recurrence and Survival in Breast Cancer Patients William McGuire, L. G. Dressler The Journal of Urology Breast OncologyPathologyOncologyGenitourinary CancerBreast Cancer Patients	1986	50

Page 1